Shareholders' Equity

9 Months Ended

Nov. 25, 2012

Shareholders' Equity [Abstract]

Shareholders' Equity

10.SHAREHOLDERS' EQUITY

During the 39 weeks ended November 25, 2012, the Company issued 6,587 shares pursuant to the exercise of stock options and recognized stock-based compensation expense and tax benefits from stock-based compensation of $643 and $0, respectively. These transactions resulted in the $802 increase in additional paid-in capital during the period.

The Company announced on October 18, 2012 that its Board of Directors had authorized the Company's purchase, on the open market and in privately negotiated transactions, of up to 1,000,000 shares of its common stock, representing approximately 5% of the Company's 20,802,020 total outstanding shares as of the close of business on October 17, 2012. During the 13 weeks ended November 25, 2012, the Company purchased 3,905 shares pursuant to such authorization at an aggregate purchase price of $93, leaving 996,095 shares that may be purchased pursuant to such authorization.